Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 01, 2023

SELL
$0.4 - $0.63 $10,182 - $16,036
-25,455 Reduced 63.04%
14,924 $6,000
Q2 2023

Aug 04, 2023

BUY
$0.51 - $0.67 $19,786 - $25,994
38,798 Added 2454.02%
40,379 $22,000
Q1 2023

Apr 27, 2023

BUY
$0.6 - $0.91 $720 - $1,092
1,200 Added 314.96%
1,581 $1,000
Q4 2022

Feb 02, 2023

SELL
$0.48 - $5.33 $72 - $810
-152 Reduced 28.52%
381 $0
Q3 2022

Nov 04, 2022

BUY
$4.65 - $7.37 $2,478 - $3,928
533 New
533 $2,000

Others Institutions Holding TIL

About Instil Bio, Inc.


  • Ticker TIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,694,000
  • Market Cap $2.67B
  • Description
  • Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...
More about TIL
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.